Change in CSF dynamics responsible for ICP elevation after ischemic stroke in rats: a new mechanism for unexplained END? by Alshuhri, Mohammed S. et al.
 
 
 
 
 
 
Alshuhri, M. S. , Gallagher, L., McCabe, C.  and Holmes, W. M.  (2020) Change in CSF 
dynamics responsible for ICP elevation after ischemic stroke in rats: a new mechanism 
for unexplained END? Translational Stroke Research, 11, pp. 310-318.  
(doi: 10.1007/s12975-019-00719-6) 
 
There may be differences between this version and the published version. You are  
advised to consult the publisher’s version if you wish to cite from it. 
 
 
 
http://eprints.gla.ac.uk/190426/ 
      
 
 
 
 
 
 
Deposited on 17 July 2019 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Change in CSF dynamics responsible for ICP elevation after ischemic stroke in rats: A new 
mechanism for unexplained END? 
Mohammed S. Alshuhri1,2, MSc; Lindsay Gallagher1, HNC; Christopher McCabe1, PhD; William M. Holmes1, PhD  
1. Glasgow Experimental MRI Centre (GEMRIC) (M.S.A., L.G., C.M., W.M.H), Institute of Neuroscience and 
Psychology, Garscube Estate, University of Glasgow, Glasgow, Scotland, United Kingdom. 
2. Radiology and Medical Imaging Department, College of Applied Medical Sciences, Prince Sattam bin 
Abdulaziz University, Kharj, Saudi Arabia, 
Corresponding Author: Dr William Holmes, Glasgow Experimental MRI Centre, Wellcome Surgical Institute, 
Garscube Estate, University of Glasgow, Glasgow, Scotland, United Kingdom, G61 1QH. Tel: ++44 141 330 6984. 
Email: William.Holmes@glasgow.ac.uk  
 
Abstract 
 
It has been proposed that intracranial pressure (ICP) elevation and collateral failure are responsible for unexplained 
early neurological deterioration (END) in stroke. The study’s aims were to investigate whether cerebral spinal fluid 
(CSF) dynamics, rather than edema, are responsible for elevation of ICP after ischemic stroke. Permanent middle 
cerebral artery occlusion (pMCAO) was induced with an intraluminal filament. At 24hrs after stroke,  baseline ICP 
was measured and  CSF dynamics were probed via a steady-state infusion method. Diffusion weighted imaging 
(DWI) and T2 weighted magnetic resonance imaging were performed to define cerebral ischemic damage and the 
volume of brain swelling. We found that the pMCAO group exhibited a significant increase in CSF outflow 
resistance (2.27 ± 0.15 mmHg.μL-1.min) compared with the sham group (0.93 ± 0.06 mmHg.μL-1.min, p = 0.002). 
There was no correlation between mean ICP at 24hrs post-pMCAO and edema (r2 = - 0.03, p = 0.5) or infarct 
volumes (r2 = 0.09, p = 0.5). However, for the first time, we found a significant correlation between the baseline ICP 
at 24hrs post-stroke and the value of CSF outflow resistance. Results show that CSF outflow resistance, rather than 
edema, was the mechanism responsible for ICP elevation following ischemic stroke. This challenges current 
concepts and suggests the possibility that intracranial hypertension may be occurring undetected in a much wider 
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range of stroke patients than is currently considered to be the case. In addition, this further supports the hypothesis 
that unexplained Early Neurological Deterioration is the result of elevated ICP, leading to reduced collateral flow 
and cerebral perfusion. 
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Introduction 
 
 
Early neurological deterioration (END) can occur within the first 24-48 hours following acute ischemic stroke, with 
prevalence being relatively common (>14%), and is strongly associated with poor outcome [1]. END was defined as 
an increase in the National Institutes of Health Stroke Scale (NIHSS) score of > 4 points within the first 24hrs after 
admission [2]. Although some cases of END have a straightforward cause, such as symptomatic intracranial 
hemorrhage and malignant edema, approximately ~2/3 of cases remain unexplained [3]. These unexplained END 
cases are associated with persistent proximal occlusion, large diffusion-perfusion mismatch, and diffusion weighted 
imaging lesion growth beyond the initial ischemic penumbra [3].  Several mechanisms have been proposed, 
involving either compromised hemodynamics (thrombus extension [1], collateral failure [4], reduced mean arterial 
pressure [5]) or other tissue-based mechanisms (excitotoxicity [6], inflammation [7], hyperthermia [8], edema [9], 
hyperglycemia [3], hypoxia [10]). Although these mechanisms may make some contribution, there is a lack of 
strong evidence associating them with END. An intriguing alternative mechanism has recently been proposed 
suggesting that elevated intracranial pressure (ICP), resulting in reduced collateral flow and cerebral perfusion, may 
be responsible for unexplained END [11]. However, the mechanism for this rise in ICP is currently unknown.   
Conventionally, only patients with large malignant strokes are considered to be at risk of elevated ICP, due to space 
occupying vasogenic edema within the closed cranial compartment. This logic has been extended to infer that ICP 
does not become elevated in cases of smaller, non-malignant strokes, since there is little or no vasogenic edema. 
However, we can find no evidence in the clinical literature to support this broad assumption, presumably because the 
risks associated with invasive ICP measurement prevent its use.   
This assumption is also contradicted by recent animal experiments, which show dramatic increases in ICP occurring 
around 24hrs after stroke onset, even following small strokes where there is little or no vasogenic edema [12]. This 
evidence leads us to hypothesize that a mechanism, other than edema, is responsible for ICP elevation in these cases. 
Inspection of a mathematical model of ICP indicates that changes in the cerebral spinal fluid (CSF) dynamics may 
be responsible for the observed increases in ICP post-ischemic stroke [13,14]. Therefore, in the present study, we 
have investigated the relationship between CSF dynamics, vasogenic edema, and ICP following experimental stroke. 
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Materials and Methods 
 
Animals and experimental protocol 
 
Experiments were carried out under license from the UK Home Office in accordance with the Animals (Scientific 
Procedures) Act, 1986, incorporating European Directive 2010/63/EU and approved by the University of Glasgow 
Ethical Review Panel. Male Wistar Kyoto (WKY) rats (350 to 400 g, 24 to 32 weeks old) were initially anesthetized 
(5% isoflurane in 20:80 O2/air mixture) in an induction chamber, then intubated, and artificially ventilated (with 2-
3% isoflurane in 20:80 O2/air mixture at flow rate 1-2 L/min). Body temperature was monitored throughout surgery 
with a rectal thermocouple and maintained at 37±0.5°C. The femoral artery was cannulated with PE-50 tubing for 
continuous monitoring of arterial blood pressure and heart rate (Biopac Systems, MP100) and for the measurement 
of arterial blood gases (Bayer, Rapidlab 248). Animals were randomly allocated to either a permanent middle 
cerebral occlusion group (pMCAO, n=8) or a sham surgery group (sham, n=6).  
 
Middle Cerebral Artery Occlusion 
 
Permanent occlusion of the left MCA was performed by intraluminal thread occlusion, as previously described [15]. 
The left common carotid artery was isolated and an arteriotomy was performed to allow for the insertion of a 4-0 
nylon silicone coated tip monofilament (403934PK10 or 404134PK10 Doccol Corporation, USA) through the 
internal carotid artery until it blocked the origin of the MCA.  The filament was left in place to induce a pMCAO.  
For sham group rats, surgery to reveal the MCA was carried out but the artery was not occluded. Immediately 
following pMCAO, rats were transferred to the MRI scanner and diffusion weighted imaging (DWI) was conducted 
to assess baseline lesion volume. Rats were then recovered from the anaesthesia and, 24hrs after pMCAO, re-
anaesthetised for assessment of final infarct volume using T2 weighted MRI. The animal was then transferred into 
the surgery room for ICP measurements. The experimental protocol is shown schematically in Fig. 1.  
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Intracranial pressure (ICP) measurement  
 
Following MRI scanning at 24hrs post-MCAO or sham surgery, rats were re-anesthetized (5% isoflurane in 20:80 
O2/air mixture) and transferred to a stereotaxic frame where the head was secured in ear and tooth bars. The co-
ordinates (Bregma 1.3 mm posterior, 2 mm lateral) for the lateral ventricles were identified from the rat brain 
stereotaxic atlas (Paxinos & Watson) and, where necessary, adjusted slightly to accommodate any brain swelling 
identified on the T2 weighted MRI scans. Two burr holes were drilled over the ipsilateral and contralateral lateral 
ventricles and, for ICP monitoring, a 25-gauge needle connected by an air-free fluid system was placed in the 
ipsilateral ventricle and attached to a pressure transducer for continuous ICP recording. The probe was secured to 
the skull with cyanoacrylate glue to avoid leakage. The correct position of the ICP probe within the ventricle was 
confirmed by the presence of CSF pulsation within the catheter. Prior to ICP recording, pressure transducers were 
calibrated with a Sphygmomanometer and the ICP waveform signal was confirmed by response to abdominal 
compression, ensuring clear cardiac and respiratory waveforms were visible.  
 
CSF infusion 
 
CSF dynamics were probed via a steady-state infusion method [16], involving stepwise increases in the 
intracerebroventricular infusion of artificial cerebrospinal fluid (aCSF) (Supplemental Figure. 1). A catheter was 
inserted into the contralateral lateral ventricle and secured to the skull with cyanoacrylate glue, then connected to an 
infusion pump (Graseby /3150 Syringe Pump). The baseline ICP pressure was monitored for 30 minutes before 
starting infusion of aCSF (aCSF: NaCl 140 mmol/L, KCl 3 mmol/L, NaH2PO4 12 mmol/L, NaHCO3 18 mmol/L, 
CaCl2 2.5 mmol/L, pH 7.4). The infusion rate was adjusted incrementally 1.67, 3.33, 5.00, 8.30, 11.67, 16.67, 25.00 
and 33.3 μL/min), with 3-6 minutes allowed for a steady-state ICP to be established after each increase. During the 
infusion experiment, mean arterial pressure (MAP) and ICP were continuously monitored in all rats. Blood gases 
(pH, partial pressure of oxygen [PaO2], carbon dioxide [PaCO2] were measured before and after the infusion. 
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Mathematical modeling 
 
Marmarou and colleagues [14] developed a mathematical model of the CSF/ICP system. Here we have extended 
their steady-state case to include growth in brain edema. In the closed cranial cavity, steady-state ICP exists when 
rates balance.  
                       𝑄𝑝𝑟𝑜𝑑 +  𝑄𝑒𝑑𝑒𝑚𝑎 = 𝑄𝑎𝑏𝑠                                  (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 1) 
Where, Qprod is the rate of CSF production and Q edema is the rate of edema growth. Assuming the rate of CSF 
absorption across the arachnoid villi, Qabs, is proportional to the corresponding pressure drop ∆𝑃 =  𝑃𝐼𝐶𝑃 − 𝑃𝑠𝑠 , 
where the venous sagittal sinus pressure Pss is small, with a CSF outflow resistance R, gives 
𝑃𝐼𝐶𝑃 =  𝑅 𝑄𝑎𝑏𝑠 = 𝑅(𝑄𝑝𝑟𝑜𝑑 + 𝑄𝑒𝑑𝑒𝑚𝑎)         (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2)  
 In the case of the steady state infusion experiments, as the rate of infusion of aCSF is greater than (𝑄𝑝𝑟𝑜𝑑 +
𝑄𝑒𝑑𝑒𝑚𝑎), this becomes 
                        𝑃𝐼𝐶𝑃 =  𝑅 𝑄𝑎𝑏𝑠 ≅ 𝑅 𝑄𝑖𝑛𝑓 + 𝑐                       (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 3) 
where  𝑄𝑖𝑛𝑓 is the rate of infusion of aCSF. It can be seen from equation 3 that the CSF outflow resistance is then 
obtained from the slope of the plot  ∆𝑃  𝑣𝑠  𝑄𝑖𝑛𝑓.   
 
Magnetic Resonance Imaging and Analysis 
 
MRI data were acquired using a Bruker Pharmascan 7T/16cm system (Ettlingen, Germany) with a gradient coil 
insert (internal diameter = 90 mm, 300 mT/m) and a four-channel phased-array surface receive coil used for brain 
imaging. During MRI scanning, a pilot sequence was first acquired to determine the correct geometry. A diffusion 
weighted imaging (DWI) scan (4-shot, spin-echo, EPI)  was performed 30 minutes after MCAO, allowing 
quantitative apparent diffusion coefficient (ADC) maps to be produced (echo time [TE] = 22 ms, repetition time 
[TR] = 4,000 ms, matrix = 96 x 96, field of view = 25mm x 25 mm, three directions = x, y, z, B values = 0 and 
1,000 s/mm2, eight coronal slices; 1.5 mm thickness). A T2-weighted (RARE) scan was performed to assess infarct 
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volume at 24hrs (effective echo Time [TE] = 46.6 ms, repetition time [TR] = 5,000 ms, RARE factor 8, averages 2, 
matrix 256 × 256, FOV 3.0 cm × 3.0 cm, 8 slices, 0.75 mm thickness).  
 
Data Analysis 
Quantitative ADC maps, in units of square millimeters per second, were calculated from the Stejskal-Tanner 
equation using Image J software (http://rsb.info. nih.gov/ij/. A 23% reduction in mean contralateral ADC was used 
to determine ischemia lesion volume from the multi-slice ADC maps [18] (Supplemental Figure. 2). Infarct volume 
was determined at 24hrs from T2-weighted images by manual tracing of the hyperintense lesion area on each slice. 
This was then summed and multiplied by the slice thickness (Supplemental Figure. 3). The edema-corrected lesion 
volume (LVe) and the space occupying effect in percent of edema uncorrected lesion volume (SE) were calculated 
from equations derived by Gerriets [18]: 
𝐿𝑉𝑒 = 𝐻𝑉𝑐 + 𝐻𝑉𝑖 − (𝐻𝑉𝑐 + 𝐻𝑉𝑖 − 𝐿𝑉𝑢) ×   
𝐻𝑉𝑐 + 𝐻𝑉𝑖
2𝐻𝑉𝑐
         (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 4) 
                     𝑆𝐸 = 𝐿𝑉𝑢 − 𝐿𝑉𝑒                                                                      (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 5) 
HVi and HVc refer to the volumes of the ipsilateral and contralateral hemispheres, respectively. LVu represents the 
uncorrected lesion volume as delineated on the T2W images. All volumetric measurements were performed 
independently by two independent investigators. To examine interobserver reproducibility, investigator 2 
determined infarct and edema volumes on the same images and the calculated values were compared with the results 
performed by investigator 1. Any cases with >10% discrepancy was flagged for review. 
 
Exclusion criteria  
 
A total of 14 Wistar Kyoto (WKY) rats were used in this series of experiments. Two animals in the MCAO group 
were excluded due to technical problems (CSF leaks, unstable BP and death). Hence, 12 animals were available for 
data analysis (6 in each group). 
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Impact of aCSF infusion on edema size 
 
To ensure that infusion of aCSF does not contribute to the development of brain edema, a pilot experiment was 
conducted with the same infusion rates and durations used in the original experiments (experimental details are 
described in Supplemental Figures 4 and 5). Serial T2 MRI revealed that there is no change in edema with aCSF 
infusion.  
 
Statistical analysis 
 
A sample size calculation was performed using pilot data (G*Power v.3.1.3 software) [19], which estimated that six 
animals per group were required to detect a 60% difference in CSF outflow resistance and 12 mmHg difference in 
ΔICP between the sham and pMCAO groups with standard settings of alpha 0.05, power 0.8. Students t-tests were 
performed on physiological parameters for illustrative purposes to highlight changes between pMCAO and sham 
rats. Mann–Whitney U-tests were performed to compare mean ICP and CSF resistance values between sham and 
post-stroke groups. Spearman’s correlation analysis was used to determine the correlation between ICP and edema 
volume, infarct volume and CSF resistance. For the CSF infusion test, statistical analysis was performed with the 
Wilcoxon signed-rank test on ICP, MAP and cerebral perfusion pressure (CPP) to detect differences between each 
infusion step point and baseline values. Data are presented as mean ± standard deviation unless otherwise stated. All 
tests were considered statistically significant for p values <0.05.  
 
Results 
 
ICP and Physiological variables  
 
ICP oscillation with pulse pressure and respiration was detected in all experiments (Fig. 2a). Median ICP at baseline 
in the pMCAO group at 24hrs (18.6 ± 5.84 mmHg) was demonstrated to be significantly greater than the sham 
group (6.01 ± 0.56 mmHg) (p=0.002) (Fig. 2b).  Physiological variables before and after infusion of aCSF are 
shown in Table 1. MAP was slightly lower at baseline in the pMCAO rats compared with the sham operated rats, 
however, this difference was not statistically significant. CPP (MAP – ICP) was significantly lower at baseline in 
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pMCAO rats compared with the sham operated rats (65 ± 10 mmHg vs. 89 ± 8 mmHg, p = 0.049). There were no 
statistically significant differences between groups for intra-operative physiological indices with the exception of 
PaCO2 (Table 1).   
Edema and Infarct volume vs. ICP  
 
Mean edema volume was 128.4 ± 19.3 mm3 (range 100-146 mm3) at 24hrs post-MCAO (online-only Data 
Supplemental Figure. 2). The growth rate of edema formation (0.09 ± 0.01 µ/min) was estimated by dividing the 
edema volume by 1,440 minutes (i.e. 24hrs). Mean edema-corrected infarct volume was 342.5 ± 65 mm3 (range 
225–397 mm3). There was no significant correlation between mean ICP at 24hrs and infarct volume (r2 = 0.09, p = 
0.5) or edema volume (r2 = - 0.03, p = 0.5) (Figs. 3a and 3b).  
ICP response to aCSF infusion  
 
The time course for MAP, CPP and ICP changes after aCSF infusion in both pMCAO and sham groups is shown in 
Figure 4. After the start of aCSF infusion, ICP increased significantly (p < 0.001 for all time points) in both the 
pMCAO and sham group. Figure 5a shows how the steady state ICP changed from baseline (ΔICP) increases with 
increasing infusion rate. For both groups, plotting ΔICP versus infusion rate resulted in a linear relationship, in 
confirmation of equation 3. At the end of infusion, ICP dropped to the initial baseline value.   
CSF outflow resistance 
 
CSF outflow resistance was calculated for each animal, as in equation 3, from the initial slope of the ΔICP vs 
infusion rate plots, for infusion rates between 0 and 11.67 μL min-1 (Fig. 5b). The mean CSF outflow resistance 
measured for the pMCAO group (2.27 ± 0.15 mmHg.μL-1.min) was significantly greater than in the sham operated 
rats (0.93 ± 0.06 mmHg.μL-1.min) (p = 0.002) (Fig. 5c). A significant relationship was found between CSF outflow 
resistance and baseline ICP measured at 24hrs, using both pMCAO and sham rats (r2 = 0. 85, p < 0.0001) (Fig. 5d).  
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CSF production rate  
 
Linear regression of the initial ICP verse infusion rate data to zero ICP (Fig. 5a) allowed an indirect estimation of 
CSF production rate, indicating no  significant change in CSF production rate following stroke (1.4 ± 1.54 µL/min 
µL/min) compared to sham controls (1.9 ± 1.49 µL/min) (p = 0.6). 
 
Discussion 
 
It is conventionally assumed that ICP elevation post-stroke is the result of cerebral vasogenic edema within the 
closed cranial compartment. Consequently, only patients with large malignant strokes and significant levels of brain 
edema are assumed to be affected by intracranial hypertension. Though this view has persisted over several decades, 
we can find no evidence in the clinical literature to support this broad assumption, presumably because the risks 
associated with invasive ICP measurements have precluded their use in the vast majority of stroke patients. Recently 
this assumption has been challenged by animal experiments, which show ICP can become substantially elevated at 
24hrs, even following small ischemic strokes (sub-cortical lesions) where there is little or no ‘space occupying’ 
edema.   Further, these previous studies found no correlation between edema volume and baseline ICP at 24hrs post-
stroke [12,20]. Data from the present study support these findings and also show an absence of correlation between 
edema volume and baseline ICP in the pMCAO group (Fig. 3) (Spearman correlation r = - 0.03, p = 0.5). However, 
since our power calculations were based on CSF outflow resistance pilot data, the sample size used (n=6) is likely 
underpowered with regard to definitively determining a lack of correlation.  
It has previously been proposed that increases in ICP in the first 24hrs post-ischemic stroke may provide an 
explanation for patients suffering a progressive stroke or unexplained END [21]. The effect of increasing ICP on 
collateral flow has been recently demonstrated in rats, using fluorescent microspheres to quantify flow through 
individual pial collateral vessels [22]. This showed progressive reductions in collateral flow with stepwise increases 
in ICP (up to 50% reduction in flow at 30mmHg). Consistent with these earlier studies, we found even minor 
increases in ICP resulted in a decrease in the critical cerebral perfusion pressure (CPP) which is the driving pressure 
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of the cerebral blood flow in the absence of autoregulation [23]. Although CPP is regulated by both MAP and ICP, it 
is remarkable how little attention the ICP component has received [23,24].  
It has been suggested that any reductions in the already tenuous penumbral perfusion would be expected to impact 
penumbral survival, leading to late infarct expansion and END. Indeed, collateral failure has been associated with 
infarct growth and has been proposed as a potential mechanism of unexplained END [25]. In support of this, recent 
clinical imaging studies have shown infarct growth beyond the initial penumbra and the occurrence of “new DWI 
lesions” at day 7 post-stroke, outside the initial area of hypo-perfusion [26]. In addition, there have been numerous 
rodent studies of both permanent and transient MCAO which have shown infarct volume expanding beyond 24hrs 
[27,28]. 
This raises the important question: if not edema, what mechanism is responsible for the substantial ICP elevations 
seen at 24hrs post-ischemic stroke? Inspection of the steady-state model of ICP (equation 2) shows ICP is dependent 
upon CSF outflow resistance, the rate of CSF production and the rate of edema growth. In confirmation of the 
mathematical model (equation 3), we found a linear relationship between the increase in ICP above baseline (ΔICP) 
and the infusion rate of aCSF (Fig. 5a) for both pMCAO and sham groups. Measured values of CSF outflow 
resistance for the sham group (0.93 ± 0.06 mmHg.μL-1.min) were consistent with previous measurements for rats, 
which ranged from 0.5 to 1.8 mmHg.μL-1.min [29,30].   
For the first time, we have shown that CSF outflow resistance increases significantly at 24hrs post-pMCAO 
compared with a sham operated group (Fig 5c). This more than a two-fold increase in CSF outflow resistance 
following ischemic stroke and is of a similar magnitude to increases previously encountered in studies on 
hydrocephalic rats [31]. Further, for the first time, we found a significant correlation between the baseline ICP at 
24hrs post-pMCAO and the value of CSF outflow resistance (Fig. 5d).  
The slow rate of CSF production is difficult to measure, with an estimate of the rate being made by extrapolating the 
initial ICP vs infusion data back to zero ICP. For the sham operated group this gave the rate of CSF production as 
1.9 ± 1.49 µL/min, slightly lower than comparable data found in the literature (3.7 ± 0.1 µL/min) measured using a 
ventriculo-cisternal perfusion technique [32]. We found the rate of CSF production did not significantly change in 
the pMCAO group (1.4 ± 1.54 µL/min) compared to the sham group (1.9 ± 1.49 µL/min) (p=0.6).  Moreover, in the 
pMCAO group, the rate of edema growth (0.09±0.01 µL/min) was found to be small compared with rate of CSF 
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production. Taken together, these results indicate the ICP elevation seen at 24hrs post-pMCAO was primarily driven 
by increased CSF outflow resistance rather than an increased rate of CSF production or edema growth.  
In all mammalian species, CSF is produced mainly by the choroid plexus located in the ventricular system. After 
circulating throughout the natural fluid passages of the ventricular system and subarachnoid space, CSF is returned 
to the vascular system via diverse outflow pathways, including arachnoid granulations (villi) and along the cervical 
lymphatic system via the olfactory perineural space (see Supplemental Figure 6) [33]. In addition, recent work 
suggests that part of the CSF is recirculated into the brain via low resistance glymphatic pathways on the surface of 
the brain that facilitate CSF circulation [34]. It appears likely that the increase in CSF outflow resistance in the 
pMCAO group found in this study, was the result of impairment of one or more of these CSF absorption pathways.  
A progressive increase in ICP can potentially lead to increased high-velocity microvascular shunt (MVS) flow 
which, in turn, promotes the development of brain edema [35]. In Figure 5a, there is evidence that the slope of the 
ICP versus infusion rate data changes above 11.7 μL min-1. To avoid this complication, CSF resistance (i.e. the 
slope) was measured using only the lower infusion rate (low ICP) data, where the brain system has been least 
perturbed (Fig. 5b). 
In summary, these are important results as they demonstrate CSF outflow resistance, not edema, is the mechanism 
responsible for ICP elevation approximately 24hrs post-ischemic stroke. This suggests the possibility that 
intracranial hypertension may be occurring undetected in a much wider range of stroke patients than is currently 
considered, not just in patients with large malignant strokes and significant levels of brain edema. The results 
presented here, in conjunction with the work of Professor Sprat and colleagues [4,12,21,22,36] and Professor Baron 
[1], are consistent with the following mechanism behind unexplained END (see Supplemental Figure 7); First, 
following ischemic stroke, changes in CSF dynamics, namely increased CSF outflow resistance, can result in a 
transient elevation of ICP at approximately 24hrs from stroke onset. Second, these increases in ICP then lead to a 
progressive reduction in collateral flow and cerebral perfusion in the occluded arterial territory. Third, the tissue that 
was initially asymptomatic (outside initial ischemic core/penumbra) then becomes at risk and ultimately evolves into 
infarct, leading to delayed infarct expansion and END. Future work is needed to fully investigate the temporal 
changes in CSF dynamics and ICP post-ischemic stroke, and how they impact on temporal changes in cerebral blood 
flow, tissue at risk and infarct evolution. 
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